Puriblood Medical Co., Ltd. (TPEX:6847)
Taiwan · Delayed Price · Currency is TWD 77.20
-0.60 (-0.77%)
Aug 19, 2026, 10:19 AM CST
Puriblood Medical Market Cap
Puriblood Medical has a market cap or net worth of 1.11 billion as of August 18, 2026. Its market cap has increased by 4.15% in one year.
Market Cap
1.11B
Enterprise Value
1.11B
Revenue
80.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
77.20
ChartMarket Cap Chart
Since November 5, 2021, Puriblood Medical's market cap has decreased from 1.83B to 1.11B, a decrease of -39.46%. That is a compound annual growth rate of -9.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 1.11B | 8.06% |
| Dec 31, 2025 | 1.02B | -28.36% |
| Dec 31, 2024 | 1.43B | -10.67% |
| Dec 29, 2023 | 1.60B | -16.97% |
| Dec 27, 2022 | 1.93B | -16.36% |
| Dec 30, 2021 | 2.31B | 26.07% |
| Nov 5, 2021 | 1.83B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIONET | 3.05B |
| DIVA Laboratories | 1.94B |
| Genetics Generation Advancement | 1.06B |
| Kim Forest Enterprise | 800.09M |
| Sofiva Genomics | 728.78M |
| TFBS Bioscience | 686.55M |
| Welgene Biotech | 390.35M |
| Pharmigene | 365.87M |